PPAR-alpha

Class

Selective PPAR-alpha modulator

PPAR-alpha (peroxisome proliferator-activated receptor alpha) is a nuclear receptor, a protein that resides inside the cell nucleus and acts as a ligand-activated transcription factor. When bound by an activating molecule, it turns on a set of genes that govern how the body processes fats, particularly the breakdown of fatty acids and the handling of lipoproteins, the particles that carry cholesterol and triglycerides in blood. Activating PPAR-alpha lowers circulating triglycerides and raises high-density lipoprotein (HDL) cholesterol, which is why this pathway has long been a target in dyslipidemia and cardiovascular risk management, particularly for patients with elevated triglycerides. Older drugs in this class, the fibrates, activate PPAR-alpha broadly but also produce off-target effects such as liver enzyme changes and interactions with other lipid-lowering drugs. A selective PPAR-alpha modulator is designed to engage the receptor in a way that favors the desired metabolic gene programs while minimizing engagement of pathways responsible for unwanted effects, aiming for a more favorable balance between triglyceride-lowering benefit and tolerability than less selective agonists of the same receptor.